OS Therapies Incorporated (OSTX)

United States Steel Statistics

Total Valuation

OS Therapies has a market cap or net worth of $57.51 million. The enterprise value is $53.58 million.

Market Cap	57.51M
Enterprise Value	53.58M

Important Dates

The next estimated earnings date is Monday, August 18, 2025, before market open.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

OS Therapies has 33.44 million shares outstanding. The number of shares has increased by 270.21% in one year.

Current Share Class	33.44M
Shares Outstanding	33.44M
Shares Change (YoY)	+270.21%
Shares Change (QoQ)	-2.34%
Owned by Insiders (%)	19.50%
Owned by Institutions (%)	1.17%
Float	24.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	3.13
PS Ratio	n/a
Forward PS	n/a
PB Ratio	92.15
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.16

Current Ratio	1.16
Quick Ratio	0.84
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.14

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-263.81%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-1,566.99%
Revenue Per Employee	n/a
Profits Per Employee	-$2.65M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.65%
50-Day Moving Average	1.74
200-Day Moving Average	2.21
Relative Strength Index (RSI)	47.96
Average Volume (20 Days)	302,783

Short Selling Information

The latest short interest is 8,931, so 0.03% of the outstanding shares have been sold short.

Short Interest	8,931
Short Previous Month	n/a
Short % of Shares Out	0.03%
Short % of Float	0.04%
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.18M
Pretax Income	n/a
Net Income	-13.27M
EBITDA	-11.18M
EBIT	-11.18M
Earnings Per Share (EPS)	-$0.82

Balance Sheet

The company has $2.97 million in cash and n/a in debt, giving a net cash position of $2.97 million or $0.09 per share.

Cash & Cash Equivalents	2.97M
Total Debt	n/a
Net Cash	2.97M
Net Cash Per Share	$0.09
Equity (Book Value)	613,666
Book Value Per Share	-0.20
Working Capital	559,091

Cash Flow

Operating Cash Flow	-10.08M
Capital Expenditures	n/a
Free Cash Flow	-10.08M
FCF Per Share	-$0.30

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-270.21%
Shareholder Yield	-270.21%
Earnings Yield	-23.47%
FCF Yield	-17.83%

Analyst Forecast

The average price target for OS Therapies is $18.00, which is 946.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	946.51%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2